EORTC Quality of Life Group (QLG)
@EORTC_QLG
Followers
1K
Following
917
Media
299
Statuses
890
The mission of the @EORTC QLG is to develop measures of PRO in #cancer, incl. #HRQoL, and promote and coordinate studies concerning the #QoL of cancer patients.
Joined April 2016
📢 Attending #EAPM2025? Today, our @EORTC #QualityofLife Group member Ines Rathgeber will report on the development of an e-learning course focusing on the use of EORTC PRO measures for quality of life assessment in clinical practice 👇 https://t.co/LwZCk23I0r
@EAPM_psych
0
1
6
👏 Proud to see this new policy review by Ian Tannock et al. in @TheLancetOncol! It highlights the need for standardised HRQoL responder criteria for better patient care & clinical decision-making. 👉 https://t.co/PLAUnWehFX
@csoncol @EORTC
#QualityofLife #GivingVoice2Patients
eortc.org
A new publication in EJC outlines EORTC's strategy for the measurement of health-related quality of life and patient-reported outcomes in oncology.
đź”” New in @TheLancetOncol: Policy review led by Ian Tannock & Madeline Pe with EORTC & @csoncol underscores why patient quality of life must be central in advanced cancer trials. đź“– Read more: https://t.co/aNjfzuaJQN
#CancerResearch #QualityofLife #GivingVoice2Patients
1
7
15
🎯 New date! Join EORTC on 24 Sept 2025 for Treatment Optimisation: Making Cancer Treatment Accessible & Sustainable in Europe, hosted by Mrs Tilly Metz at the @Europarl_EN. 🗓️ 24 Sept 📍 EU Parliament & online 🔗 https://t.co/7X3iixxrwQ ⚠️ Previous registrations invalid.
0
2
4
📢Final reminder to please register by 1st September (extended deadline) if you wish to attend @EORTC #QualityofLife Group autumn Meeting 2025: 📅25-26 September 📍Copenhagen 🇩🇰 🔗Registration link in invitation email 🔎Info on programme etc: https://t.co/qDgDX7uXjm
#QLGmeeting
0
2
8
🚨Important findings in study by K Taylor et al. on life after head & neck cancer: long-term toxicities affect most survivors — highlighting the need for better patient support & tailored follow-up care👇 #CancerCare #Survivorship #GivingVoice2Patients #QualityofLife
@EORTC @uicc
New @uicc International Journal of Cancer study by K. Taylor et al. for @EORTC_QLG & @EortcY Head & Neck Cancer (HNC) Group: 68% of long-term HNC survivors face moderate–severe toxicities. Insights can guide patient info & survivorship care. https://t.co/syyKX0n5DS
#CancerCare
0
1
4
Are cancer treatments truly optimised for patients? Our CEO, Denis Lacombe, shares why treatment optimisation must be central to cancer care, and how EU policy can help. đź”— https://t.co/QsYl2akb3l
#CancerCare #TreatmentOptimisation
1
1
8
🧠New publication on survivors of oligodendroglioma highlights long-term impacts on health-related #qualityoflife and cognitive functioning. An international cross-sectional study from the @EORTC Quality of Life Group study team. 🔗 https://t.co/Sj6Xs9SpXB
#GivingVoice2Patients
1
1
6
📅 Reminder: Registration is open for the @EORTC #QualityofLife Group (QLG) autumn meeting, to be held on 25-26 September in Copenhagen! ⏰ Register by 19th August to secure your place! 🔗More info including on venue & programme: https://t.co/qDgDX7vv8U
#QLGmeeting
0
0
7
📢 A unique opportunity to contribute to meaningful, patient-focused research in oncology. If you are looking to deepen your experience in #QualityofLife studies within clinical trials, this @EORTC Fellowship is an excellent step forward. Join our team!👇 https://t.co/l8lFcgO2Wc
eortc.org
The EORTC offers a one-year research fellowship (renewable to a maximum of 2 years) to an early-career researcher.
🚨 Fellowship opportunity at EORTC! Passionate about patient-centred research in oncology? Join EORTC’s #QualityofLife team in Brussels for hands-on experience in designing, managing & analysing QoL studies in cancer trials. Apply now 👉 https://t.co/7JNmVMIBFW
@EORTC_QLG
0
2
6
📢Attending @LeedsHospitals Research & Innovation Conference today? 🎤@RosePeacock2 is presenting a poster on behalf of @EORTC #QualityofLife Group on the current use of customised Patient-Reported Outcome (PRO) item lists in #CancerResearch. More info: https://t.co/lI9FJqq7yD
0
1
4
🎤“#EUHTA's regulation offers a framework for collaborative assessment, potentially speeding up patient access to new treatments. But it overlooks treatment optimisation & post-licensing studies. Balanced systems are key to patient-centricity,” Denis Lacombe at EU HTA conference.
0
1
1
📣 Registration is now open for the @EORTC #QualityofLife Group (QLG) autumn meeting, on 25-26 September in Copenhagen 🇩🇰! ✉️ Registration link sent to EORTC QLG members by email today 🔎 More info incl. on venue & programme available here: https://t.co/qDgDX7uXjm
#QLGmeeting
0
1
4
📢 A team of international researchers establish the @EORTC QLQ-F17 as an equivalent to the EORTC QLQ-C30 to assess functioning in cancer patients. 👉 Learn more about this recent study in the related news release we have just published: https://t.co/mXTfau8vfb
#QualityofLife
qol.eortc.org
Study by Florian Zeman et al. confirms the EORTC QLQ-F17 as an equivalent to the EORTC QLQ-C30 to assess functioning in cancer patients.
🚀 New publication by Florian Zeman et al. shows that future clinical studies can use the @EORTC QLQ-F17 questionnaire as a generic tool without losing comparability to studies using the QLQ-C30. 🔗 https://t.co/KYGWVza8vP
#CancerResearch #QualityofLife #GivingVoice2Patients
0
2
10
đź”— More information on the 9th UK #PROMs conference including the programme: https://t.co/muKisEKAba
@unibirmingham #GivingVoice2Patients
0
0
1
🎤 Excited to share another presentation today at 9th UK #PROMs conference! 👉 Christopher Bedding from @EORTC #QualityofLife (QoL) Group will present new guidelines for the use of patient-reported outcome (PRO) item libraries to allow more flexible PRO assessment in #CancerCare
1
0
6
đź”— More information on the 9th UK #PROMs conference including the programme:
0
0
0
🔎 With the @EORTC QLQ-ANL27, patients with anal cancer now have a validated health-related quality of life (HRQoL) tool post-chemoradiotherapy—reliable, sensitive & multilingual. Supporting better outcomes worldwide. #CancerCare #GivingVoice2Patients @SCSodergren
1
0
0
🧑‍⚕️ Adolescents & Young Adults (AYAs) (14–39 years) face unique cancer-related challenges. The @EORTC QLQ-AYA30 captures what matters to them—autonomy, identity, body image & more. Developed with input from 253 AYAs across 19 countries. #GivingVoice2Patients @SCSodergren
1
0
0
👏 @SCSodergren from @EORTC #QualityofLife (QoL) Group presenting today at the 9th UK #PROMs conference! ⏩QLQ-AYA30, 1st QoL tool for Adolescents & Young Adults with cancer ⏩QLQ-ANL27, validated QoL measure for anal cancer post-chemoradiotherapy #CancerResearch @unibirmingham
1
0
4
🌟 Kicking off the first official day of #STATS2025🌟 🔍Our participants will acquire a greater understanding of the statistical principles whilst avoiding too technical formulations #CancerResearch #ClinicalTrials #StatisticalMethods #ClinicalResearch #StatisticsForResearch
0
2
7